Real-world Treatment Patterns and Outcomes with Systemic Therapies in Unresectable Locally Advanced and Metastatic Cutaneous Squamous Cell Carcinoma in Germany

Real-world Treatment Patterns and Outcomes with Systemic Therapies in Unresectable Locally Advanced and Metastatic Cutaneous Squamous Cell Carcinoma in Germany

Advanced cutaneous squamous cell carcinoma is a challenge to treat. Conventional systemic treatment options include chemotherapy and epidermal growth factor receptor-inhibitors. The aim of this study was to assess clinical outcomes with systemic treatments in advanced cutaneous squamous cell carcino...

Full description

Bibliographic Details
Main Authors:	Felix Kramb, Christoph Doerfer, Andreas Meiwes, Karthik Ramakrishnan, Thomas Eigentler, Claus Garbe, Ulrike Keim, Ulrike Leiter
Format:	Article
Language:	English
Published:	Medical Journals Sweden 2022-01-01
Series:	Acta Dermato-Venereologica
Subjects:	advanced squamous cell carcinoma chemotherapy EGFR-inhibition
Online Access:	https://medicaljournalssweden.se/actadv/article/view/751

Similar Items

Epidemiology of Keratinocyte Skin Cancer with a Focus on Cutaneous Squamous Cell Carcinoma
by: Lena Nanz, et al.
Published: (2024-01-01)

Immune Checkpoint Blockade in Advanced Cutaneous Squamous Cell Carcinoma: What Do We Currently Know in 2020?
by: Anja Wessely, et al.
Published: (2020-12-01)

Current Aspects and Future Considerations of EGFR Inhibition in Locally Advanced and Recurrent Metastatic Squamous Cell Carcinoma of the Head and Neck
by: Bhamini Patel, et al.
Published: (2021-07-01)

Health-Related Quality of Life with Pembrolizumab in Patients with Locally Advanced or Recurrent or Metastatic Cutaneous Squamous Cell Carcinoma: KEYNOTE-629
by: Åse Bratland, et al.
Published: (2023-11-01)

Advanced or Metastatic Cutaneous Squamous Cell Carcinoma: The Current and Future Role of Radiation Therapy in the Era of Immunotherapy
by: Gianluca Ferini, et al.
Published: (2022-04-01)

Promising targets and current clinical trials in metastatic non-squamous NSCLC
by: Alona eZer, et al.
Published: (2014-11-01)

Efficacy of icotinib in advanced lung squamous cell carcinoma
by: Shuai Liang, et al.
Published: (2018-09-01)

Paclitaxel and cisplatin with or without cetuximab in metastatic esophageal squamous cell carcinoma: a randomized, multicenter phase II trial
by: Zhihao Lu, et al.
Published: (2022-05-01)

Treatment of Unresectable Cutaneous Squamous Cell Carcinoma with Cemiplimab in a Patient on Dialysis
by: Stacy Grace de Lima, et al.
Published: (2023-03-01)

Clinical outcomes among unresectable, locally advanced, and metastatic cutaneous squamous cell carcinoma patients treated with systemic therapy
by: C. Lance Cowey, et al.
Published: (2020-10-01)

Biology and Treatment Advances in Cutaneous Squamous Cell Carcinoma
by: Alesha A. Thai, et al.
Published: (2021-11-01)

Isolated Limb Perfusion for the Treatment of Unresectable In- Transit Metastases of Cutaneous Squamous Cell Carcinoma
by: Joana Barbosa, et al.
Published: (2021-06-01)

First-generation EGFR-TKI plus bevacizumab and chemotherapy for advanced EGFR-mutated non-squamous non-small-cell lung cancer: a retrospective study
by: Yahua Wu, et al.
Published: (2023-12-01)

Primary Resistance to PD-1-Based Immunotherapy—A Study in 319 Patients with Stage IV Melanoma
by: Teresa Amaral, et al.
Published: (2020-04-01)

Efficacy of Targeted Inhibitors in Metastatic Lung Squamous Cell Carcinoma With EGFR or ALK Alterations
by: Whitney E. Lewis, PharmD, et al.
Published: (2021-11-01)

Lycopene minimizes skin toxicity and oxidative stress in patients treated with panitumumab-containing therapy for metastatic colorectal cancer
by: Mauro Moroni, et al.
Published: (2021-08-01)

Nivolumab for Metastatic Cutaneous Squamous Cell Carcinoma
by: Marcos Oro-Ayude, et al.
Published: (2020-02-01)

Cutaneous Squamous Cell Carcinoma: From Biology to Therapy
by: Roberto Corchado-Cobos, et al.
Published: (2020-04-01)

Larotinib in patients with advanced and previously treated esophageal squamous cell carcinoma with epidermal growth factor receptor overexpression or amplification: an open-label, multicenter phase 1b study
by: Rongrui Liu, et al.
Published: (2021-10-01)

Primary squamous cell carcinoma of the renal parenchyma
by: P Kulshreshtha, et al.
Published: (2012-01-01)

Transethosome-based topical administration systems with enhanced penetration and dual actions for treating EGFR-overexpressed cutaneous squamous cell carcinoma
by: Wang, Wenyan, et al.
Published: (2024)

Clinical consensus on the treatment of locally advanced squamous cell carcinoma of the head and neck with anti-EGFR monoclonal antibody (2023 edition)
by: XU Tingting, HU Chaosu, LI Baosheng
Published: (2023-01-01)

Risk Factors and Diagnosis of Advanced Cutaneous Squamous Cell Carcinoma
by: Gabriella Brancaccio, et al.
Published: (2021-09-01)

Anti‐PD‐1 therapy using cemiplimab for advanced cutaneous squamous cell carcinoma in HIV patient: A case report
by: Abdurahman Alloghbi, et al.
Published: (2021-12-01)

miR-27a Downregulation Promotes Cutaneous Squamous Cell Carcinoma Progression via Targeting EGFR
by: Yinghui Wang, et al.
Published: (2020-01-01)

Synergistic Anti-Tumour Effect of Syk Inhibitor and Olaparib in Squamous Cell Carcinoma: Roles of Syk in EGFR Signalling and PARP1 Activation
by: Duen-Yi Huang, et al.
Published: (2020-02-01)

TENERGY: multicenter phase II study of Atezolizumab monotherapy following definitive Chemoradiotherapy with 5-FU plus Cisplatin in patients with unresectable locally advanced esophageal squamous cell carcinoma
by: Hideaki Bando, et al.
Published: (2020-04-01)

Metastatic Cutaneous Squamous Cell Carcinoma with Gastrointestinal Involvement: A Case Report
by: Brian Schwartz, et al.
Published: (2016-12-01)

Deoxypodophyllotoxin, a Lignan from <i>Anthriscus sylvestris</i>, Induces Apoptosis and Cell Cycle Arrest by Inhibiting the EGFR Signaling Pathways in Esophageal Squamous Cell Carcinoma Cells
by: Ah-Won Kwak, et al.
Published: (2020-09-01)

Thoracic radiotherapy and concurrent almonertinib for unresectable stage III EGFR-mutated non-small-cell lung cancer: a phase 2 study
by: Lucheng ZHU, et al.
Published: (2021-05-01)

Response to First-Line Treatment with Immune-Checkpoint Inhibitors in Patients with Advanced Cutaneous Squamous Cell Carcinoma: A Multicenter, Retrospective Analysis from the German ADOReg Registry
by: Maximilian Haist, et al.
Published: (2022-11-01)

Effectiveness and tolerability of nimotuzumab in unresectable, locally advanced/metastatic esophageal cancer: Indian hospital-based retrospective evidence
by: Sundaram Subramanian, et al.
Published: (2019-01-01)

Prognosis of sentinel node staged patients with primary cutaneous melanoma.
by: Otmar Elsaesser, et al.
Published: (2012-01-01)

Extra-Anogenital Giant Cutaneous Squamous Cell Carcinomas
by: Mateusz K. Mateuszczyk, et al.
Published: (2024-03-01)

CD109 Is a Critical Determinant of EGFR Expression and Signaling, and Tumorigenicity in Squamous Cell Carcinoma Cells
by: Shufeng Zhou, et al.
Published: (2022-07-01)

Prognostic value of Beclin 1, EGFR and ALK in non-squamous non-small cell lung cancer
by: Yanhui Wan, et al.
Published: (2022-11-01)

Epidermal growth factor receptor (<it>EGFR</it>) mutations and expression in squamous cell carcinoma of the esophagus in central Asia
by: Abedi-Ardekani Behnoush, et al.
Published: (2012-12-01)

Epidermal Growth Factor Receptor Activating Mutations in Squamous Histology of Lung Cancer Patients of Southern Bulgaria
by: Genova Silvia N., et al.
Published: (2015-12-01)

<i>EGFR</i> Mutations in Head and Neck Squamous Cell Carcinoma
by: Sindhu Nair, et al.
Published: (2022-03-01)

Antitumor Efficacy and Mechanisms of Lapatinib in Combination with Cisplatin on Esophageal Squamous Cancer Cells
by: DOU Qiaohua, et al.
Published: (2019-09-01)